Product Images Tezspire

Tezepelumab-ekko, also known as "TEZSPIRE", is a prescription drug available for subcutaneous injection only. It comes in a single-dose pre-filled syringe, which must be stored refrigerated between 36°F to 46°F (2°C to 8°C) and protected from light. The drug should not be shaken, frozen, or exposed to heat. The syringe contains 110 mg/mL of the medication. The drug is manufactured by AstraZeneca AB, located in Sodertalie, Sweden, and marketed by both Amgen Inc. and AstraZeneca AB. This information is intended only for medical professionals and is labeled as "Rx only".*

This text appears to be a diagram or visual guide for the proper use and components of a medical syringe. It includes labels for various parts such as the needle guard, plunger head, and finger flange. The diagram also includes a viewing window and label with activation clips and expiration date to ensure safe and effective use.*

This is a table presenting probabilities and results of a medical research trial that evaluates the effectiveness of a drug (TEZSPIRE) versus placebo in preventing asthma exacerbations. It shows the probability of the event (asthma exacerbation) being 0.807, and the treatment group divided into two: one group treated with TEZSPIRE, and another treated with placebo. The table also shows the number of participants in each group, and the time to the first asthma exacerbation in weeks.*